<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54-vaccines-07-00179">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zandi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Amblard</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Amichai</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bassit</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Tao</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Ollinger Russell</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Mengshetti</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Schinazi</surname>
    <given-names>R.F.</given-names>
   </name>
  </person-group>
  <article-title>Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2019</year>
  <volume>63</volume>
  <pub-id pub-id-type="doi">10.1128/AAC.00889-19</pub-id>
 </element-citation>
</ref>
